dehydroascorbic acid has been researched along with Leukemia, Erythroblastic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Getoff, N; Goldenberg, H; Krajnik, P; Mao, Y; Schweinzer, E | 1 |
| Goldenberg, H; Schweinzer, E | 1 |
2 other study(ies) available for dehydroascorbic acid and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Reduction of extracellular dehydroascorbic acid by K562 cells.
Topics: Ascorbic Acid; Chelating Agents; Chloromercuribenzoates; Dehydroascorbic Acid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethylmaleimide; Free Radicals; Humans; Leukemia, Erythroblastic, Acute; Leukocytes; p-Chloromercuribenzoic Acid; Thenoyltrifluoroacetone; Tumor Cells, Cultured | 1996 |
Ascorbate-mediated transmembrane electron transport and ascorbate uptake in leukemic cell lines are two different processes.
Topics: Ascorbic Acid; Biological Transport; Cell Membrane; Culture Media; Dehydroascorbic Acid; Electron Transport; Ferricyanides; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Lymphoma, Large B-Cell, Diffuse; Oxidation-Reduction; Tumor Cells, Cultured | 1992 |